International Clinical Trial: UROCAD-Guided Noninvasive Surveillance versus Standard Cystoscopic Surveillance for Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicenter Randomized Controlled Trial

Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127901) titled 'UROCAD-Guided Noninvasive Surveillance versus Standard Cystoscopic Surveillance for Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicenter Randomized Controlled Trial' on July 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Zhejiang Cancer Hospital

Condition: intermediate/high-risk non-muscle-invasive bladder cancer

Intervention: control group:Standard cystoscopy follow-up every 3 months for 2 years

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: control group:381;intervention group:381;

Count...